La caspofungine : du mécanisme d'action aux applications thérapeutiques
- 31 January 2006
- journal article
- review article
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 27 (1) , 32-39
- https://doi.org/10.1016/j.revmed.2005.05.012
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Zygomycosis: Reemergence of an Old PathogenClinical Infectious Diseases, 2004
- Invasive Zygomycosis in Hematopoietic Stem Cell Transplant Recipients Receiving Voriconazole ProphylaxisClinical Infectious Diseases, 2004
- Caspofungin acetate: An antifungal agentAmerican Journal of Health-System Pharmacy, 2001
- Utilisation des antifongiques dans le traitement des candidoses systémiques : antifongigramme, point sur les résistances, données pharmacologiquesAnnales Françaises dʼAnesthésie et de Réanimation, 2001
- A Randomized, Double-Blind Comparative Trial Evaluating the Safety of Liposomal Amphotericin B versus Amphotericin B Lipid Complex in the Empirical Treatment of Febrile NeutropeniaClinical Infectious Diseases, 2000
- Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year AnalysisClinical Infectious Diseases, 1999
- Resistance of Candida species to fluconazoleAntimicrobial Agents and Chemotherapy, 1995
- Secular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990The Journal of Infectious Diseases, 1993
- Opportunistic Mycoses in the Immunocompromised Host: Experience at a Cancer Center and ReviewClinical Infectious Diseases, 1992
- Nosocomial infection rates in adult and pediatric intensive care units in the United StatesThe American Journal of Medicine, 1991